Evidence map›Paper›PMID 16275752›Full record

ArticleThe Journal of cell biology2005

IGF-I increases bone marrow contribution to adult skeletal muscle and enhances the fusion of myelomonocytic precursors.

Alessandra Sacco, Regis Doyonnas, Mark A LaBarge, Mark M Hammer, Peggy Kraft, Helen M Blau

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Gene and cell therapy for muscle regeneration.Current reviews in musculoskeletal medicine · 2015
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2011
    Article
  14. Article
  15. Article
  16. Article
  17. Macrophages recruited via CCR2 produce insulin-like growth factor-1 to repair acute skeletal muscle injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2011
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alessandra SaccoDepartment of Molecular Pharmacology, Baxter Laboratory in Genetic Pharmacology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Regis Doyonnas
Mark A LaBarge
Mark M Hammer
Peggy Kraft
Helen M Blau
Baxter (United States) · USStanford University · US

Funding

Stem Cells for Brain and BrawnR01AG020961 · NIA · STANFORD UNIVERSITY · PI BLAU, HELEN M · 2002 to 2019
$5.0M
ACTIVATORS OF MUSCLE GENESR01AG009521 · NIA · STANFORD UNIVERSITY · PI BLAU, HELEN M · 1990 to 2014
$4.7M
REGULATION OF MUSCLE DEVELOPMENTR01HD018179 · NICHD · STANFORD UNIVERSITY · PI BLAU, HELEN M · 1985 to 2007
$2.7M
ACTIVATORS OF HUMAN MUSCLE GENESR37AG009521 · NIA · STANFORD UNIVERSITY · PI BLAU, HELEN M · 1995 to 2004
$2.3M
Regulator of Adult Stem Cell FateR01AG024987 · NIA · STANFORD UNIVERSITY · PI BLAU, HELEN M · 2004 to 2008
$1.7M
MOLECULAR PHARMACOLOGY OF DISEASES OF AGINGT32AG000259 · NIA · STANFORD UNIVERSITY · PI BLAU, HELEN M · 1998 to 2002
$530k
Phosphodiesterases Restrict Spontaneous Beating of Cardiac Pacemaker CellsZ01AG000259 · NIA · NATIONAL INSTITUTE ON AGING · PI LAKATTA, EDWARD · 1990 to 2008
$270k
Intramural NIH HHS Z01 AG000259NIA NIH HHS AG09521NIA NIH HHS AG20961NIA NIH HHS AG24987NIA NIH HHS R01 AG009521NIA NIH HHS R01 AG020961NIA NIH HHS R01 AG024987NIA NIH HHS R37 AG009521NIA NIH HHS T32 AG000259NIA NIH HHS TG AG00259NICHD NIH HHS HD 18179NICHD NIH HHS R01 HD018179
6 · The paper itself

Abstract

Muscle damage has been shown to enhance the contribution of bone marrow-derived cells (BMDCs) to regenerating skeletal muscle. One responsible cell type involved in this process is a hematopoietic stem cell derivative, the myelomonocytic precursor (MMC). However, the molecular components responsible for this injury-related response remain largely unknown. In this paper, we show that delivery of insulin-like growth factor I (IGF-I) to adult skeletal muscle by three different methods-plasmid electroporation, injection of genetically engineered myoblasts, and recombinant protein injection-increases the integration of BMDCs up to fourfold. To investigate the underlying mechanism, we developed an in vitro fusion assay in which co-cultures of MMCs and myotubes were exposed to IGF-I. The number of fusion events was substantially augmented by IGF-I, independent of its effect on cell survival. These results provide novel evidence that a single factor, IGF-I, is sufficient to enhance the fusion of bone marrow derivatives with adult skeletal muscle.

Indexed as

AnimalsBone Marrow CellsCell DifferentiationCell FusionCoculture TechniquesElectroporationGene Transfer TechniquesInsulin-Like Growth Factor IMiceMice, Inbred C57BLMice, TransgenicMuscle Fibers, SkeletalMuscle, SkeletalMyeloid Progenitor CellsMyoblastsRecombinant ProteinsInsulin-Like Growth Factor IRecombinant Proteins

Identifiers

PMID16275752
PMCPMC2171272
OpenAlexW2133017132

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.